In: Statistics and Probability
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after 20 days minus baseline) is the response variable.
Baseline | 0.04 | 0.02 | 0 | 0.02 | 0.45 | 0.37 |
After 20 days | 0.08 | 0.27 | 1.2 | 0.15 | 1.12 | 0 |
Difference | 0.04 | 0.25 | 1.2 | 0.13 | 0.67 | -0.37 |
Do the data give evidence at the 4 % level that the mean count of T cells is higher after 20 days on blinatumomab?
The test statistic is t = (±±0.001)
|
||
|
: mean difference in count of T cells between after 20 days on blinatumomab and baseline (beginning of the study)
(difference : after 20 days on blinatumomab - baseline (beginning of the study))
To Test whether there is evidence that the mean count of T cells is higher after 20 days on blinatumomab.
Null hypothesis :Ho :
Alternate Hypothesis : Ha : (Right Tailed test)
Sample data :
d: T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study and their difference (after 20 days on blinatumomab - baseline (beginning of the study))
n : sample size =6
Sample mean :
Baseline | After 20 days | d: Difference | d- | (d-)2 |
0.04 | 0.08 | 0.04 | -0.28 | 0.0784 |
0.02 | 0.27 | 0.25 | -0.07 | 0.0049 |
0 | 1.2 | 1.2 | 0.88 | 0.7744 |
0.02 | 0.15 | 0.13 | -0.19 | 0.0361 |
0.45 | 1.12 | 0.67 | 0.35 | 0.1225 |
0.37 | 0 | -0.37 | -0.69 | 0.4761 |
Total | 1.92 | 1.4924 | ||
Mean : = 1.92/6 | 0.32 |
Sample Size : n | 6 |
Level of significance : | 0.04 |
Degrees of Freedom : n-1 | 5 |
The test statistic is t = 1.4348;
For right tailed test
As
P-Value i.e. is greater than Level of significance i.e
(P-value:0.1054 > 0.04:Level of significance); Fail to Reject
Null Hypothesis
The data does not give enough at 4% level of significance that the mean count of T cells is higher after 20 days on blinatumomab
Do the data give evidence at the 4 % level that the mean count of T cells is higher after 20 days on blinatumomab?
Ans : No